Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017106
University of Pennsylvania, Philadelphia, PA, United States
Search grants from University of Pennsylvania
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Drug-Free Community Support Program (DFCSP) Coalition
Alcohol &Development:Effects on Cerebellar Systems
Core - Cell Culture Facility
Evaluation of Adoptive T Cell Therapy for HIV
GOALI: New Techniques for Solid-State NMR Studies of Pharmaceuticals
Recently added grants:
Core C: Biostatistics Bioinformatics Core
Quality control of the primary cilium proteome
On-Chip Expansion Microscopy
Speech rhythm acquisition
Prenatal Pathways for Poverty?s Influence on the Brains of Two Generations
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017106-004
Application #
6828838
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Related projects
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017106
/ University of Pennsylvania
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017106
/ University of Pennsylvania
Publications
Ruszczyk, Melanie; Zirpoli, Gary; Kumar, Shicha et al.
(2016)
Breast cancer risk factor associations differ for pure versus invasive carcinoma with an in situ component in case-control and case-case analyses.
Cancer Causes Control 27:183-98
Comments
Be the first to comment on this grant
